Patents by Inventor Yaling Wang
Yaling Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240091082Abstract: An ambulance-type mobile catheter room for cardiovascular interventional surgery enables interventional diagnosis and treatment devices for acute and severe cardiovascular diseases to be deployed quickly, is flexible and high in adaptability, and provides hardware devices for cardiovascular diagnosis and treatment interventional surgeons to timely diagnose and treat patients. The ambulance-type mobile catheter room for cardiovascular interventional surgery includes an ambulance. The ambulance is internally provided with an antibacterial internal environment, a robotic angiography machine system, a wireless medical Internet of Things system, a self-generating system and an auxiliary system.Type: ApplicationFiled: March 31, 2021Publication date: March 21, 2024Applicant: GENERAL HOSPITAL OF PLA NORTHERN THEATER COMMANDInventors: Yaling HAN, Jingyang SUN, Ming LIANG, Xiaozeng WANG, Yang LI, Dan LIU, Fei LI
-
Patent number: 11569303Abstract: A pixel arrangement structure of display panel and a display apparatus, which are used to solve the technical problem of low pixel aperture ratio of an organic light emitting diode display panel. Herein, a pixel arrangement structure of display panel includes: a plurality of sub-pixels including a first sub-pixel, a second sub-pixel, and a third sub-pixel; where the first sub-pixel, the second sub-pixel, and the third sub-pixel have a polygonal structure with different numbers of sides, and distances between any adjacent two of the plurality of sub-pixels are equal.Type: GrantFiled: July 29, 2020Date of Patent: January 31, 2023Assignee: YUNGU (GU'AN) TECHNOLOGY CO., LTD.Inventors: Zhihui Xiao, Junjie Huang, Ping Song, Weijian Shan, Yaling Wang, Zhiye Yang
-
Publication number: 20220330809Abstract: A holder for intervertebral foramen endoscope fusion includes an inner rod, an anti-torsion sleeve and an outer sleeve which are sleeved from inside to outside and are movable relatively along an axial direction. The inner rod is configured for pushing the expanding part inside a fusion cage. A head end of the anti-torsion sleeve is provided with an external thread section, the external thread section is configured for matching and connecting with the screw plug mounting hole of a holding body of the fusion cage, and the tail end of the anti-torsion sleeve is provided with a matching structure for matching with the bone grafting funnel. A head end of the outer sleeve is matched with the holding body of the fusion cage to restrict the rotation of the fusion cage along an axis of the fusion cage. A surgical instrument assembly is also provided.Type: ApplicationFiled: March 25, 2020Publication date: October 20, 2022Inventors: Zhenzhou LI, Guoping FAN, Xiyi HUANG, Yuanzhi XU, Yaling WANG
-
Publication number: 20220300038Abstract: A support structure member and a display device. The support structure member includes a first support assembly, including a plurality of support members arranged in a first direction, in which the plurality of support members can be slidably arranged relative to one another in the first direction, and a gap is formed between two adjacent support members, and the first support assembly is bent by each position of the gap; a second support assembly, movably arranged relative to the first support assembly at least one side of the support members in a thickness direction, in which the second support assembly includes a connecting unit and a hinge unit connected to the connecting unit, the second support assembly moves to the gap of the first support assembly, and in the gap, the hinge unit and the support members together support a to-be-supported member.Type: ApplicationFiled: June 6, 2022Publication date: September 22, 2022Applicant: Hefei Visionox Technology Co., Ltd.Inventors: Yaling Wang, Leichao Zhang, Fang Zhang, Zhengyang Li
-
Patent number: 10865404Abstract: The present invention provides an aspartase mutant, a recombinant expression vector and recombinant bacterium containing the aspartase mutant, and the use thereof, and belongs to the technical field of genetic engineering. The amino acid sequence of the aspartase mutant is as set forth in SEQ ID NO: 1. In the aspartase mutant of the present invention, on the basis of wild type aspartase (with an amino acid sequence as set out in SEQ ID NO: 3), glutamic acid at position 427 is mutated into glutamine. In the present invention, by mutating the amino acid residue at position 427 into glutamine, the polar environment near an active site is changed, and thus ammonia supply during substrate reaction is further facilitated, thereby improving an enzyme activity, enhancing the ability of the enzyme in synthesizing a ?-amino acid, and providing a practical and effective strategy for industrial production of the ?-amino acid.Type: GrantFiled: June 15, 2020Date of Patent: December 15, 2020Assignee: JIANGNAN UNIVERSITYInventors: Zhiming Rao, Yaling Wang, Jiamin Chen, Taowei Yang, Meijuan Xu, Xian Zhang, Minglong Shao, Jianing Zhang, Anqi Peng, Shuping Xu, Meiqi Wu
-
Publication number: 20200357864Abstract: A pixel arrangement structure of display panel and a display apparatus, which are used to solve the technical problem of low pixel aperture ratio of an organic light emitting diode display panel. Herein, a pixel arrangement structure of display panel includes: a plurality of sub-pixels including a first sub-pixel, a second sub-pixel, and a third sub-pixel; where the first sub-pixel, the second sub-pixel, and the third sub-pixel have a polygonal structure with different numbers of sides, and distances between any adjacent two of the plurality of sub-pixels are equal.Type: ApplicationFiled: July 29, 2020Publication date: November 12, 2020Applicant: YUNGU (GU'AN) TECHNOLOGY CO., LTD.Inventors: Zhihui XIAO, Junjie HUANG, Ping SONG, Weijian SHAN, Yaling WANG, Zhiye YANG
-
Patent number: 10526611Abstract: The present invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells, such as plant cells, wherein the host cells overexpress light-dependent short hypocotyls 10 (LSH10) protein. The methods of the invention comprise Agrobacterium-mediated transfer of T-DNA to a plant cell, wherein the T-DNA contains a DNA of interest to be inserted into a plant genome at a homologous position.Type: GrantFiled: April 3, 2015Date of Patent: January 7, 2020Assignee: Purdue Research FoundationInventors: Stanton B Gelvin, Lan-Ying Lee, Yaling Wang
-
Publication number: 20190076265Abstract: The invention discloses a one lumbar zero-profile fusion system, including a holder, opener and nailing machine. The fusion system contains a fuser body, front support block, rear support block and adjustable lever; the fuser body covers the upper fuser body I as well as lower fuser body II, matching with the upper fuser body I; both ends of the fuser body connect to the front support block and rear support block, both of which connect to an adjustable lever; the adjustable lever goes through the said fuser body; rear support block and fuser body are connected with a fixed plate; the left and right side of the fixed plate are equipped with oblong holes which are connected to the fuser body by screw axle; and, the holder is equipped with long circular projection matching with the said oblong hole.Type: ApplicationFiled: October 13, 2016Publication date: March 14, 2019Inventors: LubomÃr Subert, Yaling WANG, Guoping FAN, Xiyi HUANG, Guangpeng CAI, Wanyu QIU
-
Patent number: 10022156Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.Type: GrantFiled: September 3, 2016Date of Patent: July 17, 2018Assignees: Beijing Fule Science & Technology Development Co., Ltd.Inventors: Wenzhi Zhang, Xiyi Huang, Guoshuai Miu, Yaling Wang, Wensheng Lu, Hongyan Li
-
Publication number: 20170290607Abstract: A minimally invasive screw with double threaded plugs is provided, for connecting to a connecting rod. The screw includes an inner threaded plug, an outer threaded plug, a lengthened arm connector, a press block and a pin with a hollow ball head. The connecting rod can be fixed to the lengthened arm connector via the press block, the inner and outer threaded plugs, to prevent the vertebral body from rotating and loss of intervertebral height when the vertebral body is distracted and pressurized.Type: ApplicationFiled: September 3, 2016Publication date: October 12, 2017Inventors: Wenzhi Zhang, Xiyi Huang, Guoshuai Miu, Yaling Wang, Wensheng Lu, Hongyan Li
-
Publication number: 20170022511Abstract: The present invention provides methods and compositions for enhancing the efficiency of Agrobacterium-mediated transformation of host cells, such as plant cells, wherein the host cells overexpress LSH10 protein. The methods of the invention comprise Agrobacterium-mediated transfer of T-DNA to a plant cell, wherein the T-DNA contains a DNA of interest to be inserted into a plant genome at a homologous position.Type: ApplicationFiled: April 3, 2015Publication date: January 26, 2017Inventors: Stanton B Gelvin, Lan-Ying Lee, Yaling Wang
-
Patent number: 8637449Abstract: The present invention relates to synthetic processes useful in the preparation of macrocyclic compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus NS3 protease and have application in the treatment of conditions caused by the hepatitis C virus. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.Type: GrantFiled: August 26, 2010Date of Patent: January 28, 2014Assignee: Merck Sharp & Dohme Corp.Inventors: Zhiguo Jake Song, Yaling Wang, David M. Tellers, Laura M. Artino, David R. Lieberman
-
Patent number: 8507504Abstract: The present invention relates to a process for producing a hydrate of 3-(2,6-dichlorophenyl)-4-imino-7-[(2?-methyl-2?,3?-dihydro-1?H-spiro[cyclopropane-1,4?-isoquinolin]-7?-yl)amino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one (Compound A) or of a pharmaceutically acceptable salt of Compound A and a crystalline form of Compound A or of a pharmaceutically acceptable salt of Compound A, which are useful in the field of treatment of various cancers as a kinase inhibitor, especially as a Weel kinase inhibitor.Type: GrantFiled: June 2, 2009Date of Patent: August 13, 2013Assignee: Merck Sharp & Dohme Corp.Inventors: Shuntaro Furukawa, Taketo Ikeno, Shinji Kato, Masashi Kawasaki, Hisaki Kojima, Wataru Minagawa, Naotaka Sawada, Fuyuki Yamamoto, Sachin Lohani, Yaling Wang
-
Publication number: 20120232247Abstract: The present invention relates to synthetic processes useful in the preparation of macrocyclic compounds of Formula (I) that are useful as inhibitors of the hepatitis C virus NS3 protease and have application in the treatment of conditions caused by the hepatitis C virus. The present invention also encompasses intermediates useful in the disclosed synthetic processes and the methods of their preparation.Type: ApplicationFiled: August 26, 2010Publication date: September 13, 2012Inventors: Zhiguo Jake Song, Yaling Wang, David M. Tellers, Laura M. Artino, David R. Lieberman
-
Publication number: 20110092520Abstract: The present invention relates to a process for producing a hydrate of 3-(2,6-dichlorophenyl)-4-imino-7-[(2?-methyl-2?,3?-dihydro-1?H-spiro[cyclopropane-1,4?-isoquinolin]-7?-yl)amino]-3,4-dihydropyrimido[4,5-d]pyrimidin-2(1H)-one (Compound A) or of a pharmaceutically acceptable salt of Compound A and a crystalline form of Compound A or of a pharmaceutically acceptable salt of Compound A, which are useful in the field of treatment of various cancers as a kinase inhibitor, especially as a Weel kinase inhibitor.Type: ApplicationFiled: June 2, 2009Publication date: April 21, 2011Inventors: Shuntaro Furukawa, Taketo Ikeno, Shinji Kato, Masashi Kawasaki, Hisaki Kojima, Wataru Minagawa, Naotaka Sawada, Fuyuki Yamamoto, Sachin Lohani, Yaling Wang
-
Patent number: 7893081Abstract: This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET, that are useful in the treatment of cellular proliferative diseases, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. In particular, the invention relates to the sodium salt of N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide.Type: GrantFiled: December 17, 2008Date of Patent: February 22, 2011Assignee: Merck & Co., Inc.Inventors: Paolo Avalle, Jennifer R. Foley, Peter Mullens, Yaling Wang, Peter Yehl
-
Patent number: 7700611Abstract: The present invention relates to a process for producing crystalline trans-N-[1-(2-fluorophenyl)-S-pyrazoly]-3-ox-ospiro[6-azaisobenzofuran-1(3H),1?-cyclohexane]-4?-carboxamide and novel salts, hydrates and polymorphs thereof.Type: GrantFiled: July 24, 2006Date of Patent: April 20, 2010Assignee: Merck Sharp & Dohme Corp.Inventors: Russell R. Ferlita, Yuji Haga, Makoto Ishikawa, Keisuke Kamei, Shinji Kato, Hisaki Kojima, Aaron Moment, Nobuaki Nonoyama, Nobuya Satake, Kazuki Shigemori, Toshihiro Wada, Yaling Wang, Steven A. Weissman, Robert M. Wenslow
-
Publication number: 20100041893Abstract: The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).Type: ApplicationFiled: October 22, 2009Publication date: February 18, 2010Inventors: KEVIN R. CAMPOS, Artis Klapars, J. Christopher McWilliams, C. Scott Shultz, Debra J. Wallace, Alex M. Chen, Lisa F. Frey, Andrey V. Peresypkin, Yaling Wang, Robert M. Wenslow, Cheng-Yi Chen
-
Patent number: 7629470Abstract: The present invention is directed to a practical process for the preparation of an enamide (II) by palladium catalyzed coupling of a primary amide (IV) with a compound of structural formula (III), as shown below: As well as to crystalline forms of a compound produced by this process, in particular, an anhydrous crystal form, Form B, and crystalline solvates falling into three patterns, Type 1, Type 2, and Type 3, and crystalline intermediate compounds produced in the process. Still further, the present invention relates to the stereoselective reduction of the tetrasubstituted enamide (II) to the corresponding amide (I).Type: GrantFiled: July 1, 2005Date of Patent: December 8, 2009Assignee: Merck & Co., Inc.Inventors: Kevin R. Campos, Artis Klapars, J. Christopher McWilliams, C. Scott Shultz, Debra J. Wallace, Alex M. Chen, Lisa F. Frey, Andrey V. Peresypkin, Yaling Wang, Robert M. Wenslow, Cheng-Yi Chen
-
Publication number: 20090182002Abstract: This invention relates to salt forms of the compound N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide, an inhibitor of tyrosine kinases, in particular the receptor tyrosine kinase MET, that are useful in the treatment of cellular proliferative diseases, for example cancer, hyperplasias, restenosis, cardiac hypertrophy, immune disorders and inflammation. in particular, the invention relates to the sodium salt of N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N?-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide.Type: ApplicationFiled: December 17, 2008Publication date: July 16, 2009Inventors: Paolo Avalle, Jennifer R. Foley, Peter Mullens, Yaling Wang, Peter Yehl